This time last year,the infant formula maker’s chief executive Kristy Carr was beaming after being personally thanked by US President Joe Biden for bringing her product to the US.
ASX-listed infant formula maker will make and sell locally made product to Chinese parents through a new joint venture that opens the door to a lucrative $40 billion market.
Infant formula maker Bubs Australia wants to establish brand loyalty from parents in the world’s two biggest economies as it pursues growth,but Australia will not be left out.
A2 Milk has had its approval to import baby formula to the US deferred as it seeks to chase smaller Australian competitors in the market.
Bubs Australia is looking forward to a long future in the US market while it prepares to load a fifth and sixth plane of infant formula products for delivery.
Bubs Australia is after $63 million from investors to power its dreams of gaining a permanent foothold in the US market.
Bubs has hit the green light on a $63 million capital raising to fund its serendipitous expansion in the giant US market. It’s a production ramp up of epic proportions and at warp speed.
Bubs Australia is preparing to send 180,000 tins of infant formula to the US. Meanwhile,its much larger rival A2 Milk is still waiting for US FDA approval.
The listed infant formula expects its full year earnings and revenue to be double its initial forecasts,as US deals deliver windfall.
Infant formula maker Bubs Australia has seen its share price soar since revealing a landmark US distribution deal,but does that make it a good investment?
Infant formula maker Bubs Australia’s shares have spiked after it revealed it had unlocked a network of over 4,000 American stores.